340 related articles for article (PubMed ID: 19228266)
1. 4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.
Gebhardt R; Lerche KS; Götschel F; Günther R; Kolander J; Teich L; Zellmer S; Hofmann HJ; Eger K; Hecht A; Gaunitz F
J Cell Mol Med; 2010 Jun; 14(6A):1276-93. PubMed ID: 19228266
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
3. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
4. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
5. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
7. 3-methoxyapigenin modulates β-catenin stability and inhibits Wnt/β-catenin signaling in Jurkat leukemic cells.
Chuang KA; Lieu CH; Tsai WJ; Huang WH; Lee AR; Kuo YC
Life Sci; 2013 Apr; 92(12):677-86. PubMed ID: 23333831
[TBL] [Abstract][Full Text] [Related]
8. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats.
Figeac F; Uzan B; Faro M; Chelali N; Portha B; Movassat J
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E245-56. PubMed ID: 19920216
[TBL] [Abstract][Full Text] [Related]
9. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia.
Umar S; Wang Y; Morris AP; Sellin JH
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G599-607. PubMed ID: 17053159
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
11. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
Hu C; Dong T; Li R; Lu J; Wei X; Liu P
Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
[TBL] [Abstract][Full Text] [Related]
12. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
Braeuning A; Buchmann A
Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
[TBL] [Abstract][Full Text] [Related]
14. Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway.
Aschenbach WG; Ho RC; Sakamoto K; Fujii N; Li Y; Kim YB; Hirshman MF; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E152-8. PubMed ID: 16478782
[TBL] [Abstract][Full Text] [Related]
15. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC
Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta: homologous regulation of cell surface insulin receptor level via controlling insulin receptor mRNA stability in adrenal chromaffin cells.
Yokoo H; Nemoto T; Yanagita T; Satoh S; Yoshikawa N; Maruta T; Wada A
J Neurochem; 2007 Dec; 103(5):1883-96. PubMed ID: 17883398
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
Soda M; Willert K; Kaushansky K; Geddis AE
Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
